Hassan Hashmi, Colorectal and General Surgeon at Las Vegas Surgical Associates, shared on X:
“Promising advances in preventing postoperative adhesions!
A multicenter randomized clinical trial published in JAMA Surgery evaluated a novel powdered chondroitin sulfate adhesion barrier (SI-449) in patients undergoing open rectal cancer surgery.
Key findings:
- Postoperative adhesions: 93% in the control group vs. 45% with SI-449 (P < .001).
- Significant reductions in adhesion severity and extent.
- No device-related adverse events reported.
Encouraging findings for colorectal surgery!
Further studies are needed to determine whether these benefits translate into fewer long-term complications, including adhesive bowel obstruction.”
Title: Cross-Linked Chondroitin Sulfate Adhesion Barrier System in Open Rectal Resection: A Randomized Clinical Trial
Authors: Yukihide Kanemitsu, Eiji Hashizume, Takeshi Suto, Kazunori Yawata, Kenichi Inaoka, Kazuhiro Hiramatsu, Koji Komori, Masataka Ikeda, Nobuhiro Ishido, Masahiko Watanabe
You can also read:
Fabio Carbone: The Evolution of Robotic Colorectal Surgery Continues
